General Info
Rianne Ellenbroek, Investment Manager at FIRST Fund at BGV (BioGeneration Ventures), focuses on early-stage investments in biotech, medtech, and diagnostics companies. Her investments include companies like Phlox Therapeutics, Scenic Biotech, TargED Biopharmaceuticals, VarmX, and VectorY. Rianne’s check sizes typically align with early-stage funding ranges. She demonstrates a collaborative style, engaging with partners to foster growth and innovation in life sciences ventures.
Location: Amsterdam, Netherlands
Country: Netherlands
Industries:
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a press release and multiple news items showing Phlox Therapeutics raised €1.9M with FIRST fund/BGV participation on 6-14 November 2024. That investment (Phlox Therapeutics) is less than 6 months before the reference date, indicating recent activity within the very-active window.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Rianne Ellenbroek

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
